FDA Approved: DEFENCATH — Original Application (CorMedix Inc.)

View source ↗

Summary

Defencath is a taurolidine and heparin catheter-lock solution that received FDA approval via CorMedix's original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection
• Central Venous Catheter-related Infection

Drugs mentioned

• DEFENCATH (taurolidine and heparin)

Snippet

ORIG AP for DEFENCATH (TAUROLIDINE AND HEPARIN)